Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Clinical trial NCT00126724 · COMPLETED

Trial details

NCT number: NCT00126724
Sponsor: Targeted Genetics Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid Arthritis, Psoriatic Ankylosing Spondylitis

Start date: 2005-08-01
Primary completion: 2008-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.